NET PROFIT (x1000 DKK)
Orion Pharma AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
5
|
1
|
2 |
| Earnings before taxes |
3,694
|
6,476
|
1,362 |
| Total assets |
17,281
|
16,222
|
10,858 |
| Current assets |
16,624
|
15,492
|
10,055 |
| Current liabilities |
14,445
|
9,194
|
7,255 |
| Equity capital |
2,828
|
7,018
|
3,590 |
| - share capital |
530
|
565
|
596 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
16.4%
|
43.3%
|
33.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
21.4%
|
39.9%
|
12.6% |
| Current ratio |
115.1%
|
168.5%
|
138.6% |
| Return on equity (ROE) |
130.6%
|
92.3%
|
37.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.